Equity (Details - Warrant Activity) - Warrants [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
| Number of Warrants Outstanding, Beginning | 6,861,630 | 3,986,630 |
| Weighted Average Exercise Price Outstanding, Beginning | $ 3.24 | $ 3.99 |
| Number of Warrants Granted | 0 | 2,875,000 |
| Weighted Average Exercise Price Granted | $ 0 | $ 2.20 |
| Number of Warrants Exercised | (2,646,653) | 0 |
| Weighted Average Exercise Price Exercised | $ 0.82 | $ 0 |
| Number of Warrants Forfeited | 0 | 0 |
| Weighted Average Exercise Price Forfeited | $ 0 | $ 0 |
| Number of Warrants Expired | 0 | 0 |
| Weighted Average Exercise Price Expired | $ 0 | $ 0 |
| Number of Warrants Outstanding, Ending | 4,214,977 | 6,861,630 |
| Weighted Average Exercise Price Outstanding, Ending | $ 4.76 | $ 3.24 |
| X | ||||||||||
- Definition Warrants - Weighted Average Exercise Price Exercised No definition available.
|
| X | ||||||||||
- Definition Warrants - Weighted Average Exercise Price Expired No definition available.
|
| X | ||||||||||
- Definition Warrants Weighted Average Exercise Price Forfeited No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|